Article: Herpes simplex virus type 2 vaccines under development.

2004 AUG 3 - (NewsRx.com & NewsRx.net) -- Researchers are getting closer to developing effective herpes simplex virus type 2 vaccines.

According to recent research published in the journal Clinical and Diagnostic Laboratory Immunology, "The development of effective prophylactic and therapeutic vaccines against genital herpes has proven problematic. Difficulties are associated with the complexity of the virus life cycle (latency) and our relatively poor understanding of the mechanism of immune control of primary and recurrent disease. The types of effector cells and the mechanisms responsible for their activation and regulation are particularly important."

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!